Trademark Overview
On Thursday, December 12, 2024, a trademark application was filed for DEYAMLI with the United States Patent and Trademark Office. The USPTO has given the DEYAMLI trademark a serial number of 98898858. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 12, 2024. This trademark is owned by Kymab Limited. The DEYAMLI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, digestive diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders, Systemic Sclerosis, Hidradenitis Suppurativa, Alopecia Areata